Authorities in Hawaii and California are taking serious steps toward legalizing the regulated use of psychedelics. Both states are pioneering initiatives aimed at unlocking the therapeutic potential of substances like psilocybin and MDMA.
Under the Hawaii governor’s purview, a specialized task force called the Breakthrough Therapies Task Force has been initiated. This interdisciplinary group held its first meeting recently to explore opportunities for the state in this emerging field. Composed of a diverse set of professionals, from lawmakers to health experts, the task force aims to guide the state in offering expanded access to psychedelics that are pending federal approval.
Sean Munnelly, a task force member and an employee at the U.S. Department of Veterans Affairs, said the state is now on the precipice of “an exciting movement in health care and consciousness.” He added that for legalization to be done safely, “it is crucial” to create a multidisciplinary task force of experts.
“These individuals will be responsible for creating guidelines for safe and responsible practices here in Hawaii,” Munnelly said.
The state’s 11-member task force will look to Oregon and Colorado, which have already decriminalized or legalized some psychedelic substances. The Hawaii office said those states’ policies are “rooted in the growing body of research that is establishing psychedelics as the most promising new frontier in psychiatric care since the advent of selective serotonin reuptake inhibitors (SSRIs).”
The task force will review supply and access to psychedelics, affordability, licensing guides and integration coaches, and administrative resources. “In line with Hawaii’s commitment to wellness, resilience, and mental health care, the Breakthrough Therapies Task Force underscores the state’s dedication to exploring effective and innovative approaches to mental health treatment,” the office said. “By embracing the potential of breakthrough therapies and creating a regulated psychedelic therapy program, Hawaii aims to provide its residents with comprehensive, compassionate, and effective therapeutic care options.”
In California, similar efforts are underway. Senate Bill 58, authored by Democratic Senator Scott Wiener, seeks to decriminalize the personal possession and use of specific psychedelic substances for adults. “This research started in the 1960s, and — unfortunately — it was completely shut down by the War on Drugs, and we lost about 40 years,” Wiener said in a statement. “Over the last decade, the research has started again, and it is extremely promising.”
California’s bill would require an investment of $362,000 to establish a workgroup for therapeutic use recommendations, according to estimates from the Assembly Appropriations Committee.
In both states, public sentiment is swinging in favor of these psychedelic breakthroughs. The Hawaii Department of Health has endorsed the move, stating that descheduling would allow medical professionals to discuss these therapies more openly. It says moving toward legalization could be the best move given the likelihood that federal laws will begin to relax on psychedelics.
A recent study from the UC Berkeley Center for the Science of Psychedelics revealed that 61 percent of registered U.S. voters support the regulated therapeutic use of psychedelics, with almost half advocating for the decriminalization of personal use and possession.
This shift comes amid broader changes in the legislative landscape. In Hawaii, previous efforts to form a task force had been stalled, but with the swearing-in of Gov. Josh Green, there is renewed optimism for not just psychedelic therapies but also cannabis legalization.
In California, the legislative journey has seen its share of ups and downs, with an earlier bill by Sen. Wiener meeting a dead end. However, the Senator remains optimistic, stating, “California should lead in decriminalizing the possession and use of these substances.”
Related on Ethos:
